Robert Renninger Athira Pharma, Inc. (ATHA) insider trading activity

ATHA Quotes by TradingView

Robert Renninger is Chief Financial Officer of Athira Pharma, Inc.. Currently has a direct ownership of 109,186 shares of ATHA, which is worth approximately $503,347. The most recent transaction as insider was on Jul 01, 2025, when has been sold 2,897 shares (Common Stock) at a price of $0.29 per share, resulting in proceeds of $840. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 109K
0% 3M change
36.06% 12M change
Total Value Held $503,347

Robert Renninger Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jul 01 2025
SELL
Open market or private sale
$840 $0.29 p/Share
2,897 Reduced 2.58%
109,186 Common Stock
Jun 30 2025
BUY
Exercise of conversion of derivative security
-
12,359 Added 9.93%
112,083 Common Stock
May 19 2025
BUY
Grant, award, or other acquisition
$2,300 $0.23 p/Share
10,000 Added 9.11%
99,724 Common Stock
Jan 02 2025
SELL
Open market or private sale
$1,613 $0.56 p/Share
2,881 Reduced 3.11%
89,724 Common Stock
Dec 31 2024
BUY
Exercise of conversion of derivative security
-
12,359 Added 11.77%
92,605 Common Stock
Nov 18 2024
BUY
Grant, award, or other acquisition
$2,008 $0.55 p/Share
3,651 Added 4.35%
80,246 Common Stock
RR

Robert Renninger

Chief Financial Officer
Bothell, WA

Track Institutional and Insider Activities on ATHA

Follow Athira Pharma, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ATHA shares.

Notify only if

Insider Trading

Get notified when an Athira Pharma, Inc. insider buys or sells ATHA shares.

Notify only if

News

Receive news related to Athira Pharma, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ATHA